You can find the annual or quarterly income statement of Ekso Bionics Ord Shs here for insights into the performance and operational efficiency of Ekso Bionics Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Total revenue
--2.14M
Revenue
--2.14M
Cost of revenue
--1.07M
Operating expenses
--7.76M
R&D expenses
--583.00K
Depreciation, depletion, and amortization
--454.00K
Operating profit
---5.62M
Net non-operating interest income (expenses)
Non-operating interest expense
--143.00K
Gains from sale of securities
---384.00K
Special income (expenses)
---727.00K
Other non-operating income (expenses)
---13.00K
Income before tax
---6.88M
Income after tax
---6.88M
Net income from continuous operations
---6.88M
Net income attributable to controlling interests
---7.26M
Net income attributable to common shareholders
---7.26M
Basic earnings per share
---2.04
Diluted earnings per share
---2.04
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.